Pharmaceutical

Anju Announces New Product to Revolutionize Field Rep Efficiency with Precision-Driven Medical Information

FORT LAUDERDALE, Fla., Aug. 6, 2024 /PRNewswire/ -- Anju Software is proud to introduce MA Knowledge, a mobile application enhancing…

1 year ago

Samsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier Partner

Samsung Biologics to embed PSCI principles into business practices for responsible value chain managementSupplier Partnership reaffirms company's commitment to decarbonize…

1 year ago

Spineology® Announces $25 Million Equity Financing

– Funding to aid in acceleration of commercial growth, clinical education programs, and product development enhancements for highly-differentiated OptiMesh® implant…

1 year ago

Gelteq Strengthens Partnership with Monash Innovation Labs

Company benefits from robust ecosystem within the university, including premium facilities, talent, and expertiseMELBOURNE, Australia, Aug. 06, 2024 (GLOBE NEWSWIRE)…

1 year ago

SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug

SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by combining SciSparc’s Palmitoylethanolamide…

1 year ago

Clearmind Medicine: New Scientific Publication Shows MEAI’s Potential as a Novel Weight Loss Drug

Vancouver, Canada, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

1 year ago

SELLAS Receives EMA Orphan Drug Designation for SLS009 for Treatment of Peripheral T-cell Lymphomas

NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a…

1 year ago

Inozyme Pharma Reports Second Quarter 2024 Financial Results and Provides Business Highlights

- Complete enrollment in ENERGY 3, a pivotal trial of INZ-701 in pediatric patients with ENPP1 Deficiency, expected third quarter…

1 year ago

Nuvectis Pharma, Inc. Reports Second Quarter 2024 Financial Results and Business Highlights

FORT LEE, N.J., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage…

1 year ago

Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio’s Patented INTASYL Compound

Phio's INTASYL compound targets aging skin disordersMarlborough, Massachusetts--(Newsfile Corp. - August 6, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a…

1 year ago